Neurocrine Biosciences | Driftsomkostninger

Operating Expenses Lave om Dato
AbbVie USD 9.35B 1.76B 2024-03
Alnylam Pharmaceuticals USD 537.77M 18.35M 2024-03
Amgen USD 6.46B 469M 2024-03
BioMarin Pharmaceutical USD 570.37M 61.62M 2024-03
Gilead Sciences USD 6.88B 1.37B 2024-03



Neurocrine Biosciences Driftsomkostninger - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Jun 2024.